NMPA Approval

Pegylated Human Granulocyte Colony-stimulating Factor Injection

Approval Number

国药准字S20230049

Company北京双鹭药业股份有限公司

Registration Date

September 19, 2023

Drug Information

Generic Name

聚乙二醇化重组人粒细胞刺激因子注射液

Dosage Form

注射剂

Strength

1.0ml：1.0mg（7×10^7 IU）

Drug Type

生物制品

Registration Date

September 19, 2023

Company Information

Applicant Company

Company Name北京双鹭药业股份有限公司

Company Address

北京市海淀区阜石路69号碧桐园1号楼4层

Manufacturing Company

Company Name北京双鹭药业股份有限公司

Company Address

北京市石景山区八大处高科技园区中园路9号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

聚乙二醇化重组人粒细胞刺激因子注射液 - NMPA 批准文号 | MedPath